Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharma on the hot seat.

Nicole Huberfeld1

  • 1University of Kentucky College of Law, USA.

Journal of Health Law
|September 14, 2007
PubMed
Summary
This summary is machine-generated.

Increased legal scrutiny and evolving regulations are pushing the pharmaceutical industry toward greater self-regulation. Proactive, stringent self-governance can help avoid burdensome external mandates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Access to Justice After Medina v Planned Parenthood South Atlantic.

JAMA health forum·2026
Same author

Preemption at the Intersection of Health Care and Artificial Intelligence.

JAMA·2026
Same author

Considering Telehealth Across State Lines in Uncertain Times.

JAMA·2025
Same author

The impacts of the Dobbs ruling on US cancer care delivery.

Journal of the National Cancer Institute·2025
Same author

Decreasing Transparency for Certain Department of Health and Human Services Actions.

JAMA·2025
Same author

Celebrating 70 Years of Health Law at BU.

American journal of law & medicine·2025
Same journal

Seven years until electronic health records: the negative effects of the new Stark exceptions and anti-kickback safe harbors.

Journal of health law·2007
Same journal

Caracci and the valuation of exempt organizations.

Journal of health law·2007
Same journal

Prescription or proscription? The general failure of attempts to litigate and legislate against PBMS as "fiduciaries," and the role of market forces allowing PBMS to contain private-sector prescription drug prices.

Journal of health law·2007
Same journal

Beyond the anti-kickback statute: new entities, new theories in healthcare fraud prosecutions.

Journal of health law·2007
Same journal

Sample/recruitment process policy.

Journal of health law·2007
Same journal

Doctors, apologies, and the law: an analysis and critique of apology laws.

Journal of health law·2007
See all related articles

Area of Science:

  • Pharmaceutical Law
  • Healthcare Compliance
  • Regulatory Affairs

Background:

  • The pharmaceutical industry faces heightened scrutiny from public and private legal enforcement actions.
  • Key legal developments include OIG Compliance Guidance, Sarbanes-Oxley Act, HIPAA, and Medicare Modernization Act.
  • These factors create pressure for enhanced self-regulation within the industry.

Purpose of the Study:

  • To analyze the impact of legal enforcement actions and regulatory changes on the pharmaceutical industry.
  • To propose increased self-regulation as a proactive measure for the pharmaceutical sector.
  • To draw parallels with the hospital industry's response to Medicare reimbursement changes.

Main Methods:

  • Review of legal enforcement actions and compliance programs in the pharmaceutical industry.

Related Experiment Videos

  • Analysis of significant legislative and regulatory developments impacting pharmaceutical manufacturers.
  • Comparative case study examining the hospital industry's response to Medicare modifications.

    • Main Results:

    • Intensified legal and regulatory pressures necessitate a shift towards more robust self-governance.
    • The pharmaceutical industry can learn from the hospital sector's adaptation to significant regulatory shifts.
    • Failure to self-regulate may lead to externally imposed, potentially restrictive measures.

    Conclusions:

    • The pharmaceutical industry should adopt more rigorous self-regulation in response to current pressures.
    • Proactive self-governance can mitigate the risk of unanticipated and cumbersome external regulations.
    • Enhanced compliance and ethical practices are crucial for navigating the evolving regulatory landscape.